Jane Street’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Sell |
|
|||||
|
2025
Q1 | $3.64M | Sell |
|
|||||
|
2024
Q4 | $4.3M | Sell |
|
|||||
|
2024
Q3 | $5.41M | Sell |
|
|||||
|
2024
Q2 | $5.19M | Sell |
|
|||||
|
2024
Q1 | $5.67M | Buy |
|
|||||
|
2023
Q4 | $4.93M | Buy |
|
|||||
|
2023
Q3 | $4.38M | Buy |
|
|||||
|
2023
Q2 | $3.01M | Buy |
|
|||||
|
2023
Q1 | $2.29M | Sell |
|
|||||
|
2022
Q4 | $3.39M | Buy |
|
|||||
|
2022
Q3 | $856K | Sell |
|
|||||
|
2022
Q2 | $1.76M | Buy |
|
|||||
|
2022
Q1 | $1.59M | Sell |
|
|||||
|
2021
Q4 | $3.51M | Buy |
|
|||||
|
2021
Q3 | $3.21M | Sell |
|
|||||
|
2021
Q2 | $3.57M | Sell |
|
|||||
|
2021
Q1 | $3.99M | Buy |
|
|||||
|
2020
Q4 | $1.71M | Buy |
|
|||||
|
2020
Q3 | $311K | Buy |
|
|||||
|
2020
Q2 | $213K | Sell |
|
|||||
|
2020
Q1 | $95K | Buy |
|
|||||
|
2019
Q4 | $56K | Sell |
|
|||||
|
2019
Q3 | $48K | Sell |
|
|||||
|
2019
Q2 | $69K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $135K | Buy |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $94K | Buy |
|
|||||
|
2015
Q4 | $181K | Buy |
|
|||||
|
2015
Q3 | – | Hold |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $167K | Sell |
|
|||||
|
2014
Q2 | $1.36M | Sell |
|
|||||
|
2014
Q1 | $1.91M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $1.32M | Buy |
|
|||||
|
2013
Q2 | $85K | Buy |
|